Document:

EX-10.4

 Exhibit 10.4 

FORM OF LOCK-UP AGREEMENT 

[•], 2022 
 Imara Inc. 

Ladies and Gentlemen: 
 The undersigned signatory of this lock-up agreement (this “Lock-Up Agreement”) understands that Imara Inc., a Delaware corporation (“Public Company”), has entered into an
Agreement and Plan of Merger, dated as of October 13, 2022 (as the same may be amended from time to time, the “Merger Agreement”) with Iguana Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Public
Company, and Enliven Therapeutics, Inc., a Delaware corporation (“Merger Partner”). Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Merger Agreement. 

As a condition and inducement to Public Company to enter into the Merger Agreement and to consummate the transactions contemplated thereby, and for other good
and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned hereby irrevocably agrees that, subject to the exceptions set forth herein, without the prior written consent of Public Company, the
undersigned will not, during the period commencing upon the Closing and ending on the date that is 180 days after the Closing Date (the “Restricted Period”): 

(1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option,
right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Public Company Common Stock or any securities convertible into or exercisable or exchangeable for Public Company Common Stock (including without
limitation, Public Company Common Stock or such other securities which may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the SEC and securities of Public Company which may be issued upon
exercise or vesting, as applicable, of an option, warrant, restricted stock award or restricted stock unit, in each case to purchase, receive in the future or otherwise acquire Public Company Common Stock (collectively, “Public Company
Equity Rights”)) that are currently or hereafter owned by the undersigned (collectively, the “Undersigned’s Shares”); 

(2) enter into any swap, short sale, hedge or other agreement that transfers, in whole or in part, any of the economic consequences of
ownership of the Undersigned’s Shares regardless of whether any such transaction described in clause (1) above or this clause (2) is to be settled by delivery of Public Company Common Stock or other securities, in cash or otherwise;

 (3) make any demand for, or exercise any right with respect to, the registration of any shares of Public Company Common Stock or Public
Company Equity Rights (other than (i) such rights set forth in the Merger Agreement and (ii) the exercise of piggyback registration rights in connection with any secondary underwritten public offering of the Public Company Common Stock);
or 

  
 1 

 (4) publicly disclose the intention to do any of the foregoing. 

The restrictions and obligations contemplated by this Lock-Up Agreement shall not apply to: 

(a) transfers of the Undersigned’s Shares: 

(1) if the undersigned is a natural person, (A) to any person related to the undersigned by blood or adoption who is an immediate
family member of the undersigned, or by marriage or domestic partnership (a “Family Member”), or to a trust formed for the benefit of the undersigned or any of the undersigned’s Family Members, (B) to the
undersigned’s estate, following the death of the undersigned, by will, intestacy or other operation of Law, (C) as a bona fide gift or a charitable contribution, (D) by operation of Law pursuant to a qualified domestic order or in
connection with a divorce settlement or (E) to any partnership, corporation or limited liability company which is controlled by the undersigned and/or by any such Family Member(s); 

(2) if the undersigned is a corporation, partnership or other entity, (A) to another corporation, partnership, or other entity that
is a direct or indirect affiliate (as defined under Rule 12b-2 of the Exchange Act) of the undersigned, including investment funds or other entities that control or manage, are under common control or
management with, or are controlled or managed by the undersigned (including, for the avoidance of doubt, a fund managed by the same manager or managing member or general partner or management company or by an entity controlling, controlled by or
under common control with such manager or managing member or general partner or management company as the undersigned), (B) as a distribution or dividend to equity holders, current or former general or limited partners, members or managers (or to
the estates of any of the foregoing), as applicable, of the undersigned (including upon the liquidation and dissolution of the undersigned pursuant to a plan of liquidation approved by the undersigned’s equity holders), (C) as a bona fide gift
or a charitable contribution or (D) transfers or dispositions not involving a change in beneficial ownership; or 
 (3) if the
undersigned is a trust, to any grantors or beneficiaries of the trust; 
 provided that, in the case of any transfer or distribution pursuant
to this clause (a), such transfer is not for value and each donee, heir, beneficiary or other transferee or distributee shall sign and deliver to Public Company a lock-up agreement in the form of this Lock-Up Agreement with respect to the shares of Public Company Common Stock or Public Company Equity Rights; 

(b) the exercise or settlement of any Public Company Equity Rights (including a net or cashless exercise), and any related transfer of shares
of Public Company Common Stock to Public Company for the purpose of paying the exercise price of such Public Company Equity Rights or for paying taxes (including estimated taxes or tax withholding obligations) due as a result of such exercise;
provided that, for the avoidance of doubt, the underlying shares of Public Company Common Stock shall continue to be subject to the restrictions on transfer set forth in this Lock-Up Agreement; 

 (c) the establishment of a trading plan pursuant to Rule
10b5-1 under the Exchange Act for the transfer of Public Company Common Stock; provided that such plan does not provide for any transfers of Public Company Common Stock during the Restricted Period;

 (d) transfers by the undersigned of shares of Public Company Common Stock purchased by the undersigned on the open market or in a public
offering by Public Company, in each case following the date of the Merger Agreement; 
 (e) pursuant to a bona-fide third party tender offer,
merger, consolidation or other similar transaction made to all holders of Public Company’s capital stock involving a change of control of Public Company, provided that in the event that such tender offer, merger, consolidation or other
such transaction is not completed, the Undersigned’s Shares shall remain subject to the restrictions contained in this Lock-Up Agreement; 

(f) pursuant to an order of a court or regulatory agency; 

(g) any shares of Public Company Common Stock issued pursuant to the Merger Agreement in respect of shares of Merger Partner, if any, purchased
from the Merger Partner in the Financing; or 
 (h) consented to by the Merger Partner. 

and provided, further, that, with respect to each of (a), (b), and (c), above, no filing by any party (including any donor, donee, transferor,
transferee, distributor or distributee) under Section 16 of the Exchange Act or other public announcement shall be required or shall be made voluntarily in connection with such transfer or disposition during the Restricted Period (other than
(x) any exit filings or public announcements that may be required under applicable federal and state securities Laws or (y) in respect of a required filing under the Exchange Act in connection with the exercise or the net settlement of any
Public Company Equity Right, settled in Public Company Common Stock, that would otherwise expire during the Restricted Period, provided that reasonable notice shall be provided to Public Company prior to any such filing). 

Any attempted transfer in violation of this Lock-Up Agreement will be of no effect and null and void, regardless of
whether the purported transferee has any actual or constructive knowledge of the transfer restrictions set forth in this Lock-Up Agreement, and will not be recorded on the share register of Public Company. In
furtherance of the foregoing, the undersigned agrees that Public Company and any duly appointed transfer agent for the registration or transfer of the securities described herein are hereby authorized to decline to make any transfer of securities if
such transfer would constitute a violation or breach of this Lock-Up Agreement. Public Company may cause the legend set forth below, or a legend substantially equivalent thereto, to be placed upon any
certificate(s) or other documents, ledgers or instruments evidencing the undersigned’s ownership of Public Company Common Stock: 

 THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO AND MAY ONLY BE TRANSFERRED IN
COMPLIANCE WITH A LOCK-UP AGREEMENT, A COPY OF WHICH IS ON FILE AT THE PRINCIPAL OFFICE OF THE COMPANY. 
 The
undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this Lock-Up Agreement. All authority herein conferred or agreed to be conferred and any obligations
of the undersigned shall be binding upon the successors, assigns, heirs or personal representatives of the undersigned. 
 The undersigned understands that
if the Merger Agreement is terminated for any reason, this Lock-Up Agreement will automatically terminate, and the undersigned shall be released from all of his, her or its obligations under this Lock-Up Agreement. The undersigned understands that Public Company is proceeding with the transactions contemplated by the Merger Agreement in reliance upon this Lock-Up
Agreement. This Lock-Up Agreement will automatically terminate, and the undersigned will be released from all of his, her or its obligations hereunder, upon the date that is six (6) months after the date
of the Merger Agreement in the event that transactions contemplated by the Merger Agreement have not been consummated by such date. 
 Any and all remedies
herein expressly conferred upon Public Company will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by Law or equity, and the exercise by Public Company of any one remedy will not preclude the exercise of any
other remedy. The undersigned agrees that irreparable damage would occur to Public Company in the event that any provision of this Lock-Up Agreement was not performed in accordance with its specific terms or
were otherwise breached. It is accordingly agreed that Public Company shall be entitled to an injunction or injunctions to prevent breaches of this Lock-Up Agreement and to enforce specifically the terms and
provisions hereof in any court of the United States or any state having jurisdiction, this being in addition to any other remedy to which Public Company is entitled at Law or in equity, and the undersigned waives any bond, surety or other security
that might be required of Public Company with respect thereto. 
 In the event that any holder of Public Company’s securities that are subject to a
substantially similar agreement entered into by such holder, other than the undersigned, is permitted by Public Company to sell or otherwise transfer or dispose of shares of Public Company Common Stock for value other than as permitted by this or a
substantially similar agreement entered into by such holder, the same percentage of shares of Public Company Common Stock held by the undersigned on the date of such release or waiver as the percentage of the total number of outstanding shares of
Public Company Common Stock held by such holder on the date of such release or waiver that are subject of such release or waiver shall be immediately and fully released on the same terms from any remaining restrictions set forth herein (the
“Pro-Rata Release”); provided, however, that such Pro-Rata Release shall not be applied unless and until permission has been granted by
Public Company to an equity holder or equity holders to sell or otherwise transfer or dispose of all or a portion of such equity holders shares of Public Company Common Stock in an aggregate amount in excess of 1% of the number of shares of Public
Company Common Stock originally subject to a substantially similar agreement. The Public Company shall notify the undersigned within two (2) business days prior to the effective date of a release of any holder of Public Company Common Stock of
such holder’s obligations under a lock-up or substantially similar agreement that gives rise to a Pro-Rata Release. 

 Upon the release of any of the Undersigned’s Shares from this
Lock-Up Agreement, Public Company will cooperate with the undersigned to facilitate the timely preparation and delivery of certificates representing the Undersigned Shares without the restrictive legend above
or the withdrawal of any stop transfer instructions by virtue of this Lock-Up Agreement. 
 This Lock-Up Agreement and any claim, controversy or dispute arising under or related to this Lock-Up Agreement shall be governed by and construed in accordance with the Laws of
the state of Delaware, without regard to the conflict of Laws principles thereof. 
 This Lock-Up Agreement may be
executed in several counterparts, each of which shall be deemed an original and all of which shall constitute one and the same instrument. The exchange of a fully executed Lock-Up Agreement (in counterparts or
otherwise) by Public Company and the undersigned by facsimile or electronic transmission in .pdf format shall be sufficient to bind such parties to the terms and conditions of this Lock-Up Agreement. 

[SIGNATURE PAGE FOLLOWS] 

 
					
		 	Very truly yours,
		
	Print Name of Stockholder:	 	
		
		 	  

		 	Signature (for individuals):
		
		 	  

		 	Signature (for entities):
			
		 	By:	 	
		 		 	Name:
		 		 	Title:

 [Signature Page to Lock-Up Agreement] 

			
	 Accepted and Agreed
 by Imara
Inc.:

		
	By:	 	  

		 	Name: Rahul Ballal
		 	Title: President and Chief Executive Officer

 [Signature Page to Lock-Up Agreement]Exhibit 10.1

 

October 9, 2022

 

 

Aziyo Biologics, Inc.

12510 Prosperity Drive, Suite 370

Silver Spring, MD 20904

Email: jhamet@aziyo.com

 

	RE:	Amendment Letter

 

Ladies and Gentlemen:

 

Reference is made to that certain
Credit Agreement, dated as of August 10, 2022, by and among Aziyo Biologics, Inc., a Delaware corporation (the “Borrower”),
each of the undersigned financial institutions (individually each a “Lender” and collectively the “Lenders”)
and SWK Funding LLC, a Delaware limited liability company, in its capacity as administrative agent for the other Lenders (in such capacity,
 “Agent”) (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”).
All capitalized terms used in this amendment letter (this “Amendment Letter”) and not otherwise defined herein, shall
have the respective meanings given such terms in the Credit Agreement.

 

Borrower has requested of Agent
and Lenders, and in consideration of the premises herein contained and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, Agent and Lenders, intending to be legally bound, hereby agree that each reference to the date “October
10, 2022” in Section 7.13.1 of the Credit Agreement be replaced with “November 10, 2022.”

 

Except for the amendments
expressly set forth above, all of the terms, provisions and conditions of the Credit Agreement and the other Loan Documents shall remain
and continue in full force and effect. This Amendment Letter shall not apply to any other past, present or future deviations from the
Credit Agreement or any other Loan Document. Except as expressly provided herein, Agent or any Lender’s failure to exercise any
right, privilege or remedy as a result of the matters set forth above shall not directly or indirectly in any way whatsoever either: (a)
impair, prejudice or otherwise adversely affect Agent or any Lender’s right at any time to exercise any right, privilege, or remedy
in connection with the Credit Agreement, the other Loan Documents, any other agreement, or any other contract or instrument in connection
therewith, or (b) amend or alter any provision of the Credit Agreement, the other Loan Documents, any other agreement, or any other contract
or instrument in connection therewith, or (c) constitute any course of dealing or other basis for altering any obligations of Borrower
or any right, privilege, or remedy of Agent or any Lender under the Credit Agreement, the other Loan Documents, any other agreement, or
any other contract or instrument in connection therewith. Agent and each Lender hereby reserve all rights granted under the Credit Agreement,
the other Loan Documents, this Amendment Letter and any other contract or instrument between Borrower, Agent or any Lender in connection
therewith. Except as expressly stated herein, Agent and each Lender reserve all of their respective rights, privileges and remedies under
the Credit Agreement, the other Loan Documents, each other agreement and any other contracts or instruments executed by Borrower for the
benefit of Agent or such Lender in connection therewith.

 

     

     

    

 

Borrower hereby represents
and warrants that (i) each of the representations and warranties contained in the Credit Agreement, is true, correct and complete in all
material respects as of the date hereof; provided, however, that those representations and warranties expressly referring
to a specific date shall be true, correct and complete in all material respects as of such date and (ii) no Default or Event of Default
exists.

 

This Amendment Letter shall
not become effective until Agent has received an executed and delivered signature page to this Amendment Letter by the Borrower.

 

Borrower represents that it
has discussed this Agreement with its counsel.

 

THE
TERMS AND PROVISIONS OF SECTION 10.17 (GOVERNING LAW) AND 10.18 (FORUM SELECTION; CONSENT TO JURISDICTION) OF THE CREDIT AGREEMENT ARE
HEREBY INCORPORATED HEREIN BY REFERENCE, and SHALL APPLY TO THIS AMENDMENT LETTER MUTATIS MUTANDIS AS IF FULLY SET FORTH HEREIN.

 

This Amendment Letter
may be executed in multiple counterparts, each of which shall constitute an original hereof, and all of which taken together shall constitute
one and the same agreement. One or more counterparts of this Amendment Letter may be delivered by facsimile or electronic (including “PDF”)
transmission, with the intention that delivery by such means shall have the same effect as delivery of an original counterpart thereof.

 

[Remainder
of Page Intentionally Left Blank]

 

    -2-

     

    

 

IN WITNESS HEREOF, as of the date above-written,
the undersigned hereby agree to the terms and conditions set forth in this Amendment Letter.

 

	 	Very truly yours,
	 	 
	 	AGENT AND LENDER:
	 	 
	 	SWK FUNDING LLC
	 	As Agent and a Lender
	 	 
	 	By: 	SWK Holdings Corporation
	 	 	its sole manager
	 	 
	 	By: 	/s/ Joe D. Staggs
	 	Name: Joe D. Staggs
	 	Title:   President

 

[Additional signature pages follow]

 

     

     

    

 

	ACCEPTED AND AGREED TO:	 
	 	 
	AZIYO BIOLOGICS, INC.	 
	 	 
	By:	/s/ Matt Ferguson	 
	Name: Matt Ferguson	 
	Title:   Chief Financial Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}]]